ANDA 84214, held by Impax Labs. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 84214 (Promethazine Hydrochloride), held by Impax Labs, was first approved by FDA on Aug 14, 1974, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 14, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride25MG ยท tablet;oral | Promethazine Hydrochloride | Discontinued |
| Jan 23, 2001 | Supplement 28Labeling | Approved | None posted |
| Mar 27, 1997 | Supplement 32Labeling | Approved | None posted |
| Mar 27, 1997 | Supplement 33Labeling | Approved | None posted |
| May 30, 1996 | Supplement 30Labeling | Approved | None posted |
| Aug 16, 1991 | Supplement 29Labeling | Approved | None posted |
| Aug 14, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters